Acute phase proteins in acute coronary syndrome: an up-to-date
Michele Correale1, Antonio Totaro, Silvia Abruzzese
1Department of Cardiology, "Ospedali Riuniti"OO.RR, Foggia, Italy. opsfco@tin.it
Insights
Inflammation is key in coronary artery disease. This review examines acute phase proteins (APPs) beyond C-reactive protein (CRP) and their prognostic value in acute coronary syndrome (ACS).
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Inflammation plays a critical role in the development of atherosclerosis and coronary artery disease.
- C-reactive protein (CRP) is a well-established prognostic marker in acute coronary syndrome (ACS).
- The clinical significance of other acute phase proteins (APPs) in ACS remains incompletely defined.
Purpose of the Study:
- To review experimental and clinical evidence on the role and significance of various APPs in ACS.
- To discuss the biological and clinical implications of APPs beyond CRP in patients with ACS.
- To explore the impact of medications like statins on these inflammatory markers.
Main Methods:
- Systematic review of existing literature.
- Analysis of experimental and clinical studies.
- Synthesis of data on APP concentrations and patient outcomes.
Main Results:
- CRP is a confirmed prognostic marker in ACS.
- The roles of alpha-1-antitrypsin (A1AT), alpha-1 glycoprotein (A1GP), haptoglobin (HG), ceruloplasmin (CP), and complement fractions (C3c, C4) in ACS prognosis require further elucidation.
- The influence of therapeutic interventions on APP levels in ACS is a subject of ongoing investigation.
Conclusions:
- While CRP is a valuable marker, a comprehensive understanding of other APPs is crucial for improved ACS management.
- Further research is needed to clarify the prognostic and therapeutic implications of various APPs in ACS.
- Investigating the interplay between APPs, disease progression, and treatment response is essential.
Abstract:
Inflammation is essential for atherogenesis, and many inflammatory markers have been analyzed for their association with short- and long-term outcome in patients with manifestations of coronary artery disease. C-reactive protein (CRP) plasma levels increase in patients with acute coronary syndrome (ACS). CPR is an important prognostic marker in ACS. Although CRP will remain over time a useful marker, the role and implications of increased plasma concentrations of other acute phase proteins (APPs), such as alpha-1-antitrypsin (A1AT), alpha-1 glycoprotein (A1GP), haptoglobin (HG), ceruloplasmin (CP), and C3c and C4 complement fraction, in patients with ACS are still not completely defined. Controversy is the role of statins and other drugs on inflammatory markers. This review summarizes the experimental and clinical evidence regarding the role, and the biological and clinical significance of these APPs in ACS. Furthermore, biological and clinical significance of Pentraxin 3 (PTX3), a member of the pentraxin superfamily, are discussesed.
More Related Videos
08:51Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
Published on: September 20, 2024
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Acute Inflammation II: Cellular Phase
